6/13
12:03 pm
capr
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $77.00 price target on the stock.
Medium
Report
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $77.00 price target on the stock.
5/20
08:16 am
capr
Capricor Therapeutics Inc (NASDAQ: CAPR) is now covered by analysts at Roth Capital. They set a "buy" rating and a $31.00 price target on the stock.
Low
Report
Capricor Therapeutics Inc (NASDAQ: CAPR) is now covered by analysts at Roth Capital. They set a "buy" rating and a $31.00 price target on the stock.
5/20
08:16 am
capr
Capricor Therapeutics Inc (NASDAQ: CAPR) is now covered by analysts at Roth Capital. They set a "buy" rating and a $31.00 price target on the stock.
Low
Report
Capricor Therapeutics Inc (NASDAQ: CAPR) is now covered by analysts at Roth Capital. They set a "buy" rating and a $31.00 price target on the stock.
5/20
04:28 am
capr
Capricor Therapeutics initiated with a Buy at Roth Capital
Medium
Report
Capricor Therapeutics initiated with a Buy at Roth Capital
5/20
04:28 am
capr
Capricor Therapeutics initiated with a Buy at Roth Capital
Medium
Report
Capricor Therapeutics initiated with a Buy at Roth Capital
5/14
11:13 am
capr
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $30.00 price target on the stock.
Low
Report
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $30.00 price target on the stock.
5/14
10:45 am
capr
Rating for CAPR
Low
Report
Rating for CAPR
3/20
10:22 am
capr
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $30.00 price target on the stock.
Low
Report
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $30.00 price target on the stock.
3/20
10:08 am
capr
Rating for CAPR
Medium
Report
Rating for CAPR
3/17
12:56 pm
capr
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $77.00 price target on the stock.
Low
Report
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $77.00 price target on the stock.